Intensive hepatological studies using carphenazine

E TIANGCO. Am J Psychiatry. 1962 Mar.

. 1962 Mar:118:845-6.

doi: 10.1176/ajp.118.9.845.

No abstract available

Similar articles

Pharmacology and toxicity of carphenazine.
TISLOW R. TISLOW R. Dis Nerv Syst. 1961 Feb;22(2)Suppl:7-13. Dis Nerv Syst. 1961. PMID: 13777037 No abstract available.
Carphenazine in the treatment of chronic schizophrenics.
BARSA JA, SAUNDERS JC. BARSA JA, et al. Am J Psychiatry. 1962 Aug;119:169. doi: 10.1176/ajp.119.2.169. Am J Psychiatry. 1962. PMID: 13865331 No abstract available.
Carphenazine therapy in hospitalized patients.
KOTHARI NJ, PARK IH, KLINE NS, SAUNDERS JC. KOTHARI NJ, et al. Dis Nerv Syst. 1961 Feb;22(2)Suppl:58-9. Dis Nerv Syst. 1961. PMID: 13753477 No abstract available.
[Progress in the field of drug developments. 13].
Henkler G, Klotzbach M, Koch H, Müller W, Richter J. Henkler G, et al. Pharmazie. 1980;35(9):517-39. Pharmazie. 1980. PMID: 6107937 Review. German. No abstract available.
Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.
Hornykiewicz O. Hornykiewicz O. Annu Rev Pharmacol Toxicol. 1977;17:545-59. doi: 10.1146/annurev.pa.17.040177.002553. Annu Rev Pharmacol Toxicol. 1977. PMID: 17361 Review. No abstract available.